Acinetobacter baumannii and Tn125 Carbapenem Resistance Transposition

Acinetobacter baumannii is a strictly aerobic, non-fermenting, catalase-positive, oxidase-negative, Gram-negative coccobacillus belonging to the class Gammaproteobacteria (order Moraxellales) and designated as the leading member of the ESKAPE pathogens and a World Health Organization (WHO) Critical-Priority carbapenem-resistant pathogen (CRAB). Unlike enteric rods such as Escherichia coli or Klebsiella pneumoniae, A. baumannii possesses an AT-rich circular chromosome of ~3.9 to 4.2 Mb (GC content ≈ 38.8–39.2%), exhibits natural transformation competence for uptake of naked environmental DNA, and synthesizes dense capsular exopolysaccharides (KL locus) and biofilm-associated proteins (Bap) that enable it to survive desiccation on dry hospital plastics and stainless steel for 60 to >120 days.

In clinical epidemiology and evolutionary genomics, A. baumannii occupies a unique dual position. First, hospital-adapted International Clones IC1 (ST1) and IC2 (ST2, Oxford/Pasteur MLST) cause ventilator-associated pneumonia (VAP), bloodstream infections, and combat-wound osteomyelitis with mortality rates of 35% to 60%, driven by intrinsic (blaOXA-51-like) and acquired (blaOXA-23, blaOXA-24/40, blaOXA-58) Ambler Class D carbapenemases and gigantic chromosomal Acinetobacter baumannii Resistance Islands (AbaR, up to 86 kb) inserted into the competence ATPase gene comM. Second, comparative sequence stratigraphy demonstrates that A. baumannii served as the evolutionary intermediate bridge host in which the ancestral chimeric New Delhi metallo-beta-lactamase (blaNDM-1) gene was fused to aphA6 and bleMBL inside the composite transposon Tn125 (flanked by ISAba125 insertion sequences) prior to horizontal gene transfer into Enterobacterales and Pseudomonas aeruginosa.

The comM Hotspot and AbaR1 (86 kb) Chromosomal Resistance Islands

Comparative pangenome analysis across thousands of sequenced A. baumannii isolates reveals a conserved core genome of ~2,000–2,200 housekeeping genes coupled to an expansive, open accessory genome (>18,000 gene families) concentrated within genomic islands and conjugative plasmids (RepAci1, RepAci6, pAB3). The premier chromosomal integration hotspot for multidrug resistance in International Clone 1 (IC1) and IC2 lineages lies inside the comM gene, which encodes a 505-amino-acid AAA⁺ family Mg²⁺-ATPase containing a conserved Walker A/B motif that normally promotes Holliday-junction branch migration during natural transformation.

Site-specific insertion into a conserved 5-bp target site (5′-ACCGC-3′) within comM by a Tn7-like transposition module (tnsABCDE homologs tniCABDE) generates Acinetobacter baumannii Resistance Islands (AbaR). In the epidemic strain A. baumannii AYE (IC1), AbaR1 spans 86,190 bp and packs 45 antimicrobial and heavy-metal resistance determinants—including class 1 integrons and IS26 arrays encoding blaVEB-1 (ESBL), blaOXA-10, aminoglycoside-modifying enzymes (aacC1, aadA1, aphA1b, aadB), tetracycline efflux (tetA), chloramphenicol (catA1, cmlA), sulfonamide/trimethoprim (sul1, dfrA1/dfrA10), and mercury/arsenic resistance operons—originating from Pseudomonas, Salmonella, and Escherichia species into a single chromosomal cassette.

Outer Membrane Lipooligosaccharide (LOS) Remodeling and Desiccation Survival

Unlike canonical Gram-negative bacteria that synthesize lipopolysaccharide (LPS) bearing repeating O-antigen polysaccharide chains, A. baumannii synthesizes lipooligosaccharide (LOS) lacking O-antigen polymers (lpxABCDLMO lipid A pathway) surrounded by a high-molecular-weight capsular polysaccharide (CPS, encoded by the KL capsule locus) and poly-β-(1-6)-N-acetylglucosamine (PNAG, encoded by pgaABCD). Under hospital desiccation stress, the two-component response regulator BfmRS upregulates KL capsule synthesis, trehalose/glycine-betaine osmoprotectant accumulation, catalase (katE/katG) reactive oxygen scavenging, and the giant cell-surface Biofilm-Associated Protein (Bap, >8,000 amino acids). Furthermore, A. baumannii is one of only three known bacteria (alongside Neisseria meningitidis and Moraxella catarrhalis) capable of surviving complete genetic inactivation of lipid A biosynthesis (lpxA, lpxC, or lpxD loss-of-function mutations)—shedding its outer-membrane LOS altogether to develop resistance to polymyxin B and colistin, albeit at a fitness and virulence cost.

Sequence Stratigraphy of the aphA6–blaNDM-1–bleMBL Chimera

Prior to the global dissemination of New Delhi metallo-beta-lactamase (blaNDM-1) across Klebsiella pneumoniae and Escherichia coli, molecular dissection by Laurent Poirel, Patrice Nordmann, and Julian Davies established that the blaNDM-1 gene was originally constructed through an in-frame chimeric fusion event inside Acinetobacter baumannii. Nucleotide alignment of the 5′ end of blaNDM-1 reveals that its first 19 base pairs (6 N-terminal amino acids of the lipobox signal peptide, plus 250 bp of upstream intergenic sequence) are 100% identical to the aminoglycoside 3′-phosphotransferase gene aphA6 (amikacin resistance, native to Acinetobacter species), whereas the remainder of the 813 bp blaNDM-1 open reading frame (58.5% GC) was captured alongside the downstream bleomycin resistance gene bleMBL and truncated phosphoribosylanthranilate isomerase trpF from an environmental marine/soil alphaproteobacterium or gammaproteobacterium (Erythrobacter / Xanthomonas lineage).

Structure of Tn125 (10,099 bp) and the ISAba125 Hybrid Promoter

In clinical A. baumannii isolates (such as JH and 161/07), this chimeric blaNDM-1 cassette is preserved in its full, unfragmented ancestral configuration inside the 10,099 bp composite transposon Tn125 ( flanked by a 3-bp target-site duplication, TSD). Tn125 is bounded at both ends by two direct copies of the 1,087 bp insertion sequence ISAba125 (an IS30-family element indigenous to Acinetobacter species, bounded by 15-bp imperfect inverted repeats IRL and IRR).

Between the two flanking ISAba125 elements, Tn125 carries an invariant 8-gene cargo module in the strict order: ISAba125 — blaNDM-1 — bleMBL — trpF — dsbD (tat) — cutA — groES — groEL — insE (ISCR21) — ISAba125.

Crucially, the upstream (left-hand) copy of ISAba125 is inserted 93 bp upstream of the blaNDM-1 start codon, positioning an outward-facing -35 hexamer (5′-TTGAAT-3′) located inside the right inverted repeat (IRR) of ISAba125 at an optimal 17-bp spacer distance from the native -10 Pribnow box (5′-TACAAAT-3′) inherited from aphA6. This composite ISAba125/native hybrid promoter drives high-level constitutive transcription of the bicistronic blaNDM-1–bleMBL mRNA. When Tn125 was subsequently transferred on broad-host-range IncA/C, IncX3, and IncFII plasmids into K. pneumoniae and E. coli, secondary insertions of IS26, ISKpn14, IS903, and ISEc33 progressively truncated the downstream groES–groEL–ISCR21 segment and trimmed the upstream ISAba125 element—leaving a conserved ~100–250 bp ΔISAba125 remnant in virtually all enteric blaNDM plasmids purely because deleting the IRR -35 hexamer would silence blaNDM-1 expression.

OXA-23 (Tn2006), OXA-24/40 (XerC/XerD), and Hydrophobic Active-Site Tunnels

Although Tn125 (blaNDM-1) accounts for 5–15% of carbapenem-resistant A. baumannii (CRAB), the majority (>80%) of global CRAB isolates rely on Ambler Class D carbapenem-hydrolyzing oxacillinases (OXA-type β-lactamases), which utilize an active-site N-carboxylated lysine (Lys73/Lys82, formed by reversible reaction with dissolved CO₂) to deprotonate the nucleophilic catalytic Ser70/Ser81 residue:

1. Intrinsic Chromosomal blaOXA-51-like: Present in all A. baumannii chromosomes; confers clinically significant carbapenem resistance only when the native insertion sequence ISAba1 (1,180 bp) transposes 7 bp upstream to supply a strong outward-facing promoter.
2. Acquired blaOXA-23 (Tn2006, Tn2008, Tn2009): Captured from the environmental species Acinetobacter radioresistens and mobilized globally inside Tn2006 (bounded by two inverse copies of ISAba1), OXA-23 possesses a disulfide-like hydrophobic bridge (Phe110 and Met221) across the top of the active-site cleft that traps the hydroxyethyl side chain of imipenem and meropenem for efficient deacylation.
3. Acquired blaOXA-24/40 (OXA-72): Lacks flanking IS elements and instead mobilizes across Acinetobacter plasmids via site-specific XerC/XerD tyrosine recombinase recognition sites (pdif modules, 28 bp), using a Tyr112–Met223 hydrophobic tunnel to hydrolyze carbapenems.

Sulbactam–Durlobactam, Cefiderocol, and Zosurabalpin (LptB2FGC Inhibition)

Because Class D OXA-23 and OXA-24/40 enzymes are refractory to classical β-lactamase inhibitors (clavulanate, tazobactam) as well as first-generation diazabicyclooctanes (avibactam) and boronic acids (vaborbactam), three specialized structural therapeutics have been developed against CRAB:

1. Sulbactam–Durlobactam (Xacduro, FDA-approved 2023): In A. baumannii, sulbactam is not merely a β-lactamase inhibitor; it is an intrinsic bactericidal β-lactam antibiotic that directly acylates Penicillin-Binding Proteins PBP1a, PBP1b, and PBP3, though it is hydrolyzed by OXA-23 and TEM-1. Durlobactam (ETX2514) is a rationally expanded, double-bond-constrained diazabicyclooctane (DBO) whose reduced steric bulk and increased electrophilicity enable rapid carbamoylation of OXA-23, OXA-24/40, OXA-58, and OXA-51 (k2/K > 10^4 M−1·s−1), restoring sulbactam's bactericidal activity against PBP3 and lowering 28-day mortality in the Phase III ATTACK trial.
2. Cefiderocol (Fetroja): A catechol-cephalosporin conjugate that chelates ferric iron (Fe3+) and hijacks outer-membrane TonB-dependent siderophore receptors (PiuA, PirA) via "Trojan horse" active transport into the periplasm, bypassing porin (CarO/OmpA) loss and resisting hydrolysis by both OXA-23 and NDM-1.
3. Zosurabalpin (RG6006, Tethered Macrocyclic Peptide): Discovered via whole-cell phenotypic optimization, zosurabalpin is a first-in-class macrocyclic peptide antibiotic selective for Acinetobacter that binds a composite pocket formed by the inner-membrane lipooligosaccharide transport machine LptB2FGC plus its bound LOS substrate intermediate—jamming LOS export to the outer membrane and killing pan-resistant (OXA-23 + NDM-1 + colistin-resistant) CRAB via toxic intracellular LOS accumulation.

Why is Acinetobacter baumannii uniquely suited to act as a genetic bridge between environmental soil/water bacteria and hospital Enterobacterales?

A. baumannii combines three traits rarely found together in enteric pathogens: (1) high natural transformation competence during surface motility, allowing it to import naked chromosomal DNA from lysed environmental Acinetobacter, Pseudomonas, and soil bacteria (blaOXA-23 from A. radioresistens, blaNDM-1 from environmental proteobacteria); (2) an endogenous arsenal of hyperactive insertion sequences (ISAba1 and ISAba125) that insert upstream of silent foreign genes to supply strong outward-facing -35 promoters; and (3) co-colonization of intensive care unit patients alongside K. pneumoniae and E. coli, enabling conjugative transfer of Tn125.

Why does Sulbactam–Durlobactam fail against NDM-1-producing Acinetobacter baumannii unless paired with Cefiderocol or Aztreonam?

Durlobactam is a non-β-lactam diazabicyclooctane (DBO) that covalently carbamoylates the catalytic active-site serine (Ser70) of Class A, Class C (ADC), and Class D (OXA-23/OXA-24) β-lactamases, but it cannot bind or inhibit the binuclear Zn²⁺ active site of Class B metallo-β-lactamases such as NDM-1. Consequently, in the ~5–15% of CRAB isolates that co-harbor Tn125 (blaNDM-1), NDM-1 hydrolyzes the PBP3-targeting partner sulbactam, requiring siderophore bypass with cefiderocol or non-β-lactam LptB2FGC inhibition (zosurabalpin).

How do XerC/XerD (pdif) recombination modules mobilize blaOXA-24/40 and tet(39) without transposases?

Many Acinetobacter resistance plasmids (pAB family) lack classic transposons (Tn) or insertion sequences (IS) around their resistance genes. Instead, blaOXA-24/40, blaOXA-58, tet(39) (tetracycline resistance), and msr(E)–mph(E) (macrolide resistance) are flanked by 28-bp pdif sites consisting of an 11-bp binding site for the host chromosomal recombinase XerC and an 11-bp binding site for XerD separated by a 6-bp central spacer. The host cell's own chromosome-dimer resolution machinery (XerC/XerD) catalyzes site-specific recombination between pdif modules across distinct plasmids.

1. Poirel, L., Bonnin, R. A., Boulanger, A., Schrenzel, J., Kaase, M., & Nordmann, P. (2012). "Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii." Antimicrobial Agents and Chemotherapy, 56(2), 1087–1089. https://doi.org/10.1128/AAC.05620-11
2. Toleman, M. A., Spencer, J., Jones, L., & Walsh, T. R. (2012). "blaNDM-1 is a chimera likely constructed in Acinetobacter baumannii." Antimicrobial Agents and Chemotherapy, 56(5), 2773–2776. https://doi.org/10.1128/AAC.06297-11
3. Kaye, K. S., Shorr, A. F., Wunderink, R. G., et al. (2023). "Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)." The Lancet Infectious Diseases, 23(9), 1072–1084. https://doi.org/10.1016/S1473-3099(23)00184-600184-6)
4. Zampaloni, C., Mattei, P., Bleicher, K., et al. (2024). "A novel antibiotic class targeting the lipopolysaccharide transporter." Nature, 625(7995), 566–571. https://doi.org/10.1038/s41586-023-06873-0